Home care during neutropenia after allogeneic hematopoietic stem cell transplantation in children and adolescents is safe and may be more advantageous than isolation in hospital

Pediatric Transplantation

Volumn 18, Issue 4, 2014, Pages 398-404

  Ringdén, Olle ^a,b   Remberger, Mats ^a,b   Törlén, Johan ^b   Engström, Mats ^b   Fjaertoft, Gustav ^b   Mattsson, Jonas ^a,b   Svahn, Britt Marie ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

allogeneic hematopoietic stem cell transplantation; graft versus host disease; home care

Indexed keywords

CYCLOSPORIN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RAPAMYCIN; TACROLIMUS;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BLOODSTREAM INFECTION; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FEMALE; HEALTH CARE COST; HERPES SIMPLEX; HERPES ZOSTER; HOME CARE; HOSPITAL CARE; HOSPITALIZATION COST; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; NEUTROPENIA; OVERALL SURVIVAL; RECURRENT DISEASE; TRANSFUSION; ACUTE DISEASE; ALLOTRANSPLANTATION; CHRONIC DISEASE; COMPARATIVE STUDY; EVALUATION STUDY; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITALIZATION; INCIDENCE; INFANT; NEWBORN; PRESCHOOL CHILD; STATISTICAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

ACUTE DISEASE; ADOLESCENT; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOME CARE SERVICES; HOSPITALIZATION; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MATCHED-PAIR ANALYSIS; NEUTROPENIA; SURVIVAL RATE; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84900001737     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/petr.12262     Document Type: Article

References (31)

1. Buckner CD, Clift RA, Sanders JE, et al. Protective environment for marrow transplant recipients: A prospective study. Ann Intern Med 1978: 89: 893-901.
2. Meyers JD, Thomas ED,. Infection complicating bone marrow transplantation. In:, Rubin RH, Young LS, eds. Clinical Approach to Infection in the Immunocompromised Host. New York, NY: Alan R Liss Inc., 1983: pp. 525-556.
3. Mahmoud HK, Schaefer UW, Schuning F, et al. Laminar air flow versus barrier nursing in marrow transplant recipients. Blut 1984: 49: 375-381.
4. Passweg JR, Rowlings PA, Atkinson KA, et al. Influence of protective isolation on outcome of allogeneic bone marrow transplantation for leukemia. Bone Marrow Transplant 1998: 21: 1231-1238.
5. Skinhoj P, Jacobsen N, Hoiby N, Faber V,. Strict protective isolation in allogeneic bone marrow transplantation: Effect on infectious complications, fever and graft versus host disease. Scand J Infect Dis 1987: 19: 91-96.
6. Svahn BM, Remberger M, Myrback KE, et al. Home care during the pancytopenic phase after allogeneic hematopoietic stem cell transplantation is advantageous compared with hospital care. Blood 2002: 100: 4317-4324.
7. Svahn BM, Bjurman B, Myrback KE, Aschan J, Ringden O,. Is it safe to treat allogeneic stem cell transplant recipients at home during the pancytopenic phase? A pilot trial. Bone Marrow Transplant 2000: 26: 1057-1060.
8. Ringden O, Nilsson B,. Death by graft-versus-host disease associated with HLA mismatch, high recipient age, low marrow cell dose, and splenectomy. Transplantation 1985: 40: 39-44.
9. Ringden O, Remberger M, Holmberg K, et al. Many days at home during neutropenia after allogeneic hematopoietic stem cell transplantation correlates with low incidence of acute graft-versus-host disease. Biol Blood Marrow Transplant 2013: 19: 314-320.
10. Ringden O, Ruutu T, Remberger M, et al. A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: A report from the Nordic Bone Marrow Transplantation Group. Blood 1994: 83: 2723-2730.
11. Martensson T, Priftakis P, Casswall T, et al. Increased risk of gastrointestinal acute GVHD following the addition of melphalan to busulfan/cyclophosphamide conditioning. Pediatr Transplant 2013: 17: 285-293.
12. Storb R, Doney KC, Thomas ED, et al. Marrow transplantation with or without donor buffy coat cells for 65 transfused aplastic anemia patients. Blood 1982: 59: 236-246.
13. Beelen DW, Haralambie E, Brandt H, et al. Evidence that sustained growth suppression of intestinal anaerobic bacteria reduces the risk of acute graft-versus-host disease after sibling marrow transplantation. Blood 1992: 80: 2668-2676.
14. Ringden O, Remberger M, Persson U, et al. Similar incidence of graft-versus-host disease using HLA-A, -B and -DR identical unrelated bone marrow donors as with HLA-identical siblings. Bone Marrow Transplant 1995: 15: 619-625.
15. Schaffer M, Aldener-Cannava A, Remberger M, Ringden O, Olerup O,. Roles of HLA-B, HLA-C and HLA-DPA1 incompatibilities in the outcome of unrelated stem-cell transplantation. Tissue Antigens 2003: 62: 243-250.
16. Storb R, Deeg HJ, Pepe M, et al. Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: Long-term follow-up of a controlled trial. Blood 1989: 73: 1729-1734.
17. Ringden O, Horowitz MM, Sondel P, et al. Methotrexate, cyclosporine, or both to prevent graft-versus-host disease after HLA-identical sibling bone marrow transplants for early leukemia? Blood 1993: 81: 1094-1101.
18. Ringden O, Remberger M, Aschan J, Lungman P, Lonnqvist B, Markling L,. Long-term follow-up of a randomized trial comparing T cell depletion with a combination of methotrexate and cyclosporine in adult leukemic marrow transplant recipients. Transplantation 1994: 58: 887-891.
19. Ringden O, Remberger M, Dahllof G, et al. Sirolimus and tacrolimus as immune prophylaxis compared to cyclosporine with or without methotrexate in patients undergoing allogeneic haematopoietic stem cell transplantation for non-malignant disorders. Eur J Haematol 2011: 87: 503-509.
20. Luznik L, Bolanos-Meade J, Zahurak M, et al. High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease. Blood 2010: 115: 3224-3230.
21. Kaplan EL, Meier P,. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958: 53: 457-481.
22. Bostrom L, Ringden O, Gratama JW, et al. A role of herpes virus serology for the development of acute graft-versus-host disease. Leukaemia Working Party of the European Group for Bone Marrow Transplantation. Bone Marrow Transplant 1990: 5: 321-326.
23. Blennow O, Mattsson J, Remberger M,. Pre-engraftment blood stream infection (BSI) is a risk-factor for acute GVHD grade II-IV. Bone Marrow Transplant 2013: 48: 1583-1584.
24. Jones JM, Wilson R, Bealmear PM,. Mortality and gross pathology of secondary disease in germfree mouse radiation chimeras. Radiat Res 1971: 45: 577-588.
25. van Bekkum DW, Roodenburg J, Heidt PJ, van der Waaij D,. Mitigation of secondary disease of allogeneic mouse radiation chimeras by modification of the intestinal microflora. J Natl Cancer Inst 1974: 52: 401-404.
26. Storb R, Prentice RL, Buckner CD, et al. Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environment. N Engl J Med 1983: 308: 302-307.
27. Beelen DW, Elmaagacli A, Muller KD, Hirche H, Schaefer UW,. Influence of intestinal bacterial decontamination using metronidazole and ciprofloxacin or ciprofloxacin alone on the development of acute graft-versus-host disease after marrow transplantation in patients with hematologic malignancies: Final results and long-term follow-up of an open-label prospective randomized trial. Blood 1999: 93: 3267-3275.
28. Gerbitz A, Schultz M, Wilke A, et al. Probiotic effects on experimental graft-versus-host disease: Let them eat yogurt. Blood 2004: 103: 4365-4367.
29. Jenq RR, Ubeda C, Taur Y, et al. Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation. J Exp Med 2012: 209: 903-911.
30. Fondell E, Axelsson J, Franck K, et al. Short natural sleep is associated with higher T cell and lower NK cell activities. Brain Behav Immun 2011: 25: 1367-1375.
31. Remberger M, Ackefors M, Berglund S, et al. Improved survival after allogeneic hematopoietic stem cell transplantation in recent years. A single-center study. Biol Blood Marrow Transplant 2011: 17: 1688-1697.